Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
10.61
+0.13 (1.24%)
At close: Aug 18, 2026, 4:00 PM EDT
10.61
0.00 (0.00%)
After-hours: Aug 18, 2026, 4:04 PM EDT
Keros Therapeutics Market Cap
Keros Therapeutics has a market cap or net worth of $210.37 million as of August 18, 2026. Its market cap has decreased by -64.23% in one year.
Market Cap
210.37M
Enterprise Value
-31.52M
1-Year Change
-64.23%
Ranking
Category
Stock Price
$10.61
ChartMarket Cap Chart
Since April 8, 2020, Keros Therapeutics's market cap has decreased from $385.32M to $210.37M, a decrease of -45.41%. That is a compound annual growth rate of -9.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 210.37M | -66.09% |
| Dec 31, 2025 | 620.29M | -3.27% |
| Dec 31, 2024 | 641.23M | -46.17% |
| Dec 29, 2023 | 1.19B | -9.94% |
| Dec 30, 2022 | 1.32B | -3.39% |
| Dec 31, 2021 | 1.37B | -16.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| YD Bio | 209.55M |
| PepGen | 207.09M |
| Precision BioSciences | 205.08M |
| Innate Pharma | 202.05M |
| Voyager Therapeutics | 201.49M |
| Satellos Bioscience | 200.85M |
| Korro Bio | 195.56M |
| Corbus Pharmaceuticals Holdings | 195.15M |